RT Book, Section A1 Sanchez, Miguel A2 Nouri, Keyvan SR Print(0) ID 1194726263 T1 Skin Cancers in Patients with HIV T2 Skin Cancer: A Comprehensive Guide YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781260453003 LK dermatology.mhmedical.com/content.aspx?aid=1194726263 RD 2024/03/29 AB SUMMARYCompared with HIV-uninfected persons of the same age, persons living with HIV/AIDS (PLWH) have substantially higher risks of some cancers, called AIDS-defining cancers (ADCs), which by their mere presence confer a diagnosis of AIDS.AIDS-defining cancers (ADCs) such as Kaposi sarcoma, aggressive B-cell non-Hodgkin lymphoma, and cervical cancer are associated with loss of immunoregulation of oncogenic viruses.1The incidence of ADCs declined precipitously after the introduction of combinations of antiretroviral therapy. However, PLWH still have a 500-fold, 12-fold, and 3-fold higher risk of developing Kaposi sarcoma, non-Hodgkin lymphoma (NHL), and cervical cancer, respectively, compared with the general population.1